Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1
- Type
- Retraction
- Notice date
- 1/28/2026 0:00
- Journal
- Frontiers in Pharmacology
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fphar.2026.1791496
- Original paper DOI
- 10.3389/fphar.2024.1345645
Reasons
- Duplication of/in Image
- Investigation by Journal/Publisher
- Investigation by Third Party
- Objections by Author(s)
- Unreliable Data
- Unreliable Results and/or Conclusions